1. Preclinical Evidence of STAT3 Inhibitor Pacritinib Overcoming Temozolomide Resistance via Downregulating miR-21-Enriched Exosomes from M2 Glioblastoma-Associated Macrophages
    Hao-Yu Chuang et al, 2019, JCM CrossRef
  2. The Autophagy Status of Cancer Stem Cells in Gliobastoma Multiforme: From Cancer Promotion to Therapeutic Strategies
    Larisa Ryskalin et al, 2019, IJMS CrossRef
  3. Molecular and Cellular Complexity of Glioma. Focus on Tumour Microenvironment and the Use of Molecular and Imaging Biomarkers to Overcome Treatment Resistance
    Silvia Valtorta et al, 2020, IJMS CrossRef
  4. Synergistic Effects of Resveratrol and Temozolomide Against Glioblastoma Cells: Underlying Mechanism and Therapeutic Implications


    Yusi Liu et al, 2020, CMAR CrossRef
  5. Deciphering the Role of Autophagy in Treatment of Resistance Mechanisms in Glioblastoma
    Imran Khan et al, 2021, IJMS CrossRef
  6. Transcriptome analysis revealed CENPF associated with glioma prognosis
    Moxuan Zhang et al, 2021, MBE CrossRef
  7. Breaking Bad: Autophagy Tweaks the Interplay Between Glioma and the Tumor Immune Microenvironment
    Yuxiang Fan et al, 2021, Front. Immunol. CrossRef
  8. Canonical and Non-Canonical Roles of PFKFB3 in Brain Tumors
    Reinier Alvarez et al, 2021, Cells CrossRef
  9. Targeting Janus Kinase (JAK) for Fighting Diseases: The Research of JAK Inhibitor Drugs
    Min-Yan Zhao et al, 2022, CMC CrossRef
  10. Janus Kinase-Signal Transducer and Activator of Transcription Inhibitors for the Treatment and Management of Cancer
    Fahim Anwar Rizwi et al, 2023, J Environ Pathol Toxicol Oncol CrossRef
  11. New Salicylanilide Derivatives and Their Peptide Conjugates as Anticancer Compounds: Synthesis, Characterization, and In Vitro Effect on Glioblastoma
    Lilla Horváth et al, 2024, ACS Omega CrossRef
  12. The Masquelet technique triggers the formation of a network involving LncRNA, circRNA, miRNA, and mRNA during bone repair
    Muguo Song et al, 2024, Annals of Medicine CrossRef